Acceleron Pharma, Inc.

Q4 2017 13F Holders

Symbol
XLRN
CUSIP
00434H108
Type
Equity
Class
COM
Num filings
146
Total reported value, excl. options
$1.70 B
Manager Report Date Value ($000) Shares Option Type